A clinician may be able to justify a decision to deviate from the NICE guideline if it was reasonable and made in good faith
Jo Inge Bekkevold , a senior China fellow at the Norwegian Institute for Defence Studies
Reedijk J., Poeppelmeier K
Adding Ipamorelin to the Stack: What the Research Suggests Ipamorelin is a growth hormone secretagogue studied for its selective stimulation of growth hormone release, and its frequently searched alongside AOD-9604, MOTS-c, and Tesamorelin because it engages a fourth, distinct research pathway
Maintenance phase: Once the loading phase is complete, patients transition to maintenance therapy with 1 mg hydroxocobalamin intramuscularly every two to three months for life
The peptide is stable in stomach acid and its ability to target gut linings directly makes it safe for oral delivery in experimental settings